Preliminary Program: Tuesday, May 19
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
7:30 a.m.-6 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 55-61
9 a.m.-10:30 a.m.
Lectures
L12. To Be AnnouncedHon. Gavin Newsom, John Fryer Award
L13. Modules of the Mind: Developing a Positive Psychiatry of the PersonC. Robert Cloninger, M.D., Marmor Award Lecture
L14. Borderline Personality Disorder: The Birth Pains of the Still New DiagnosisJohn Gunderson, M.D., Distinguished Psychiatrist Lecture
Case Conferences (Open to APA members only)
CC03. Issues in the DifferentialDiagnosis of Mild TBI, PCS, and PTSD in Service Members After Blast Exposure in CombatMarvin Oleshansky, M.D.
CC04. Perspectives of PsychiatryPaul McHugh, M.D.
Debate/Roundtable
DR02. To Be Announced
Small Interactive Sessions
SI04. A Discussion and Open Forum About Drug InteractionsGary H. Wynn, M.D. (Meet the Author)
SI05. Neuropsychiatric Assessment for General PsychiatrySheldon Benjamin, M.D.
SI06. Palliative Care and Psychiatric Issues at the End of LifeWilliam Breitbart, M.D.
Component Workshops
CW10. Biracial Americans: “Check One Box Only” and the Development of Multiracial IdentityAPA Council on Minority Mental Health and Health Disparities; Chair: Jacquelyn Chang, M.D., Co-Chair: Kehinde Ogundipe, M.D.
CW11. Recognition and Treatment of Dementia in a Changing AmericaAPA Committee on Ethnic Minority Elderly; Chair: Maria llorente, M.D., Co-Chair: Khushro Unwalla, M.D.
CW12. How General Psychiatrists Can Effectively Screen and Treat Substance Use DisodersAPA Corresponding Committee on Treatment Services for Patients With Addictive Disorders; Chair: Varinder Rathore, M.D., Co-Chair: Petros Levounis, M.D.
CW13. Outpatient Forensic Services and Interventions to Improve Clinical Outcomes and Reduce RecidivismAPA Task Force on Forensic Outpatient Services; Chair: Steven Hoge, M.D., Co-Chair: Alec Buchanan, Ph.D.
CW14. National Security, the Hippocratic Oath, and the War on TerrorAPA Council on Global Psychiatry; Chair: Shirin Ali, M.D., Co-Chair: Karinn Glover, M.D.
Medical Update
MU1. 21st Century ECT—Updating the APA Recommendations on ECTTask Force to Revise the Practice of Electroconvulsive Therapy; Chair: Sarah Lisanby, M.D., Co-Chair: Richard Weiner, M.D.
Issue Workshops
IW21. Tips for Effective Communication About Genetics and Mental Illness With Patients and Their FamiliesChair: Jehannine Austin, Ph.D., Co-Chair: Holly Peay, M.S.
IW22. Clinical and Forensic Issues Concerning Infanticide, the Murder of a Child in the First Year of Life by Its MotherChair: Malkah Notman, M.D., Co-Chair: Carl Malmquist, M.D.
IW23. Extended Treatments for Alcohol Use DisordersNational Institute on Alcohol Abuse and Alcoholism; Chair: James McKay, Ph.D.
IW24. Cognitive Therapy for Personality DisordersChair: Judith Beck, Ph.D.
IW25. The Impact of Meditation as a Non-Pharmacological Intervention for Veterans With Mental Health DisordersChair: Julie Malphurs, Ph.D., Co-Chair: Daniella David, M.D.
IW26. Assessment of Capacity: Developments, Documentation, and DefendabilityChair: Michael Wise, M.B.B.S., Co-Chair: Julian Beezhold, M.D.
IW27. Lessons Learned About Resilience and Recovery Following DisastersChair: Howard Osofsky, M.D.
IW28. When Psychiatry Residents Treat Medical Students: Some ChallengesChair: Michael Myers, M.D.
IW29. Bootcamp for BurnoutAssociation of Women Psychiatrists; Chair: Tana Grady-Weliky, M.D.
IW30. Lessons From the Post-Residency Road: Four Career Journeys Since Residency Graduation in 2004, With Insights From Our Training DirectorChair: William Wood, M.D., Co-Chair: Kathy Sanders, M.D.
IW31. Assessment and Treatment of Sleep Disorders in Alcohol-Dependent Patients With ADHD and Other Co-Occurring DisordersNational Institute on Alcohol Abuse and Alcoholism; Chair: Kirk Brower, M.D., Co-Chair: Iyad Alkhouri, M.D.
IW32. Doing it Right the First Time: Recognizing, Maintaining, and Supporting Workplace FunctionAPA Corresponding Committee on Psychiatry in the Workplace; Chair: Andrea Stolar, M.D.
9 a.m.-12:30 p.m.
Media Workshops
MW3. The Joy Luck Club: Universal Stories About Mothers and Daughters From ChinaChair: Francis Lu, M.D.
MW4. Provoked: Combating Domestic ViolenceIndo-American Psychiatric Association; Chair: Vishal Madaan, M.D., Co-Chair: Surinder Nand, M.D.
9 a.m.-4 p.m.
CME Courses 62-66
10 a.m.-3 p.m.
Exhibits Open
APA Member Center Open
Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Advances In Medicine
AM02. Infertility IssuesElena Gates, M.D.
Forums
F05. Anxiety in Patients With HIV: Importance and DrugsChair: Ramaswany Viswanathan, M.D.
F06. Bridges and Barriers to Care: Current StrategiesChair: Mark Townsend, M.D.
F07. New Perspectives on Cultural Issues in AlcoholChair: Barbara McCrady, M.D.
Lectures
L15. Cross-Cultural Psychopharmacology: Shaping Our Future via Bridging Science and ServiceEdward Pi, M.D., Kun-Po Soo Award Lecture
L16. How Alcoholism Develops: Identification of Genetic and Environmental Influences in a 25-Year Longitudinal StudyMarc Shuckit, M.D., Adolf Meyer Award Lecture
L17. When Politics Distorts Science: A Psychiatrist Reports From the Trenches of the Culture WarsJack Drescher, M.D., Distinguished Psychiatrist Lecture
Small Interactive Sessions—Meet the Author
SI07. When a Physician Is Your PatientMichael Myers, M.D.
SI08. Approach to the Psychiatric PatientJohn W. Barnhill, M.D.
SI09. Brain Stimulation Therapies for CliniciansNed Higgins, M.D.
11 a.m.-12:30 p.m.
Component Workshops
CW15. Current Topics in Forensic Psychiatry: Update From the Council on Psychiatry and Law and the Committee on Judicial ActionAPA Council on Psychiatry and Law and APA Committee on Judicial Action; Chair: Patricia Recupero, M.D., J.D., Co-Chair: Jeffrey Janofsky, M.D.
CW16. Indications for the Use of Combined Talking Therapy and Pharmacotherapy and How to Teach in ResidencyAPA Corresponding Committee on Graduate Education; Chair: Sidney Weissman, M.D.
CW17. Medical Issues for Psychiatrists in DisastersAPA Committee on Psychiatric Dimensions of Disaster; Chair: Mark Viron, M.D., Co-Chair: Nidal Hasan, M.D.
CW18. Ethical Dilemmas in Psychiatric PracticeAPA Ethics Committee; Chair: Wade Myers, M.D.
Issue Workshops
IW33. The Use of Research Measures in Clinical PracticeChair: Joan Busner, Ph.D.
IW34. FFT-HPI and FIT: Two Different Approaches to Family-Involved Treatment for Bipolar DisorderChair: Igor Galynker, M.D.
IW35. Outpatient Mastectomies: Overview of Psychosocial IssuesChair: Zach Morairty, M.D., Co-Chair: Michelle Riba, M.D.
IW36. Evaluation and Management of Patients With Excessive Daytime Sleepiness in Psychiatric PracticeChair: Dimitri Markov, M.D.
IW37. The Portrayal of Psychiatry in Recent American FilmChair: Steven Pflanz, M.D.
IW38. The Changing Managed Care Landscape for Behavioral Health ServicesNational Institute on Alcohol Abuse and Alcoholism; Chair: Constance Horgan Sc.D., Co-Chair: Mark Willenbring, M.D.
11 a.m.-12:30 p.m.
Scientific and Clinical Reports
Session 09. Child and Adolescent Psychiatry
25. Medication Trends in New-Onset Pediatric Bipolar Disorder Among Medicaid-Insured Youth Aloysius Ibe, B.S., M.S.
26. Physical Activity and Fitness in Adolescents at Risk for Psychosis Jenni Koivukangas
27. Metabolic Symptoms in Adolescent Psychiatric Inpatients Michael Stevens, Ph.D.
Session 10. Cross-Cultural Psychiatry
28. Genes, Memes, Migration, and Mental Illness Hoyle Leigh, M.D.
29. One-Year Follow-Up Study of the Culturally Sensitive Collaborative Treatment (CSCT) for Chinese Americans With Depression Adrienne van Nieuwenhuizen, B.A.
30. Prevalence of Childhood Trauma in Psychiatric and Primary Care Clinics in Cities Along the U.S.-Mexico Border Alejandra Postlethwaite, M.D.
Session 11. Diagnostic Issues
31. Heterogeneity of the Jealousy Phenomenon in the General Population: An Italian Study Donatella Marazziti, M.D.
32. Olfactory Reference Syndrome (ORS): A Systematic Review of the World Literature Millia Begum, M.B.B.S., M.Eng.
33. Dimensionality and Etiology in Psychiatric Research Stephen Shanfield, M.D.
Session 12. Metabolism, Metabolic Syndrome, and Cardiovascular Disease in Schizophrenia
34. Schizophrenia-Spectrum Disorders Were Associated With Cardiovascular Disease Symptoms, Independent of Known Risk Factors for Symptoms Stephen Woolley, D.Sc., M.P.H.
35. Ultra Rapid Metabolizers Are in a Pilot Study in Two Different Clinics Over-represented in Court-Ordered Psychotic Patients Carel de Blécourt, M.D., Ph.D.
36. Oatmeal vs. Donuts: Treating Metabolic Syndrome/Obesity Using CBT/DBT in an Inner-City SPMI Population Joanne Caring, M.D.
Session 13. Diagnostic Issues in the Schizophrenia Spectrum
37. Is Schizoaffective Disorder a Distinct Clinical Entity? John Goethe, M.D.
38. Diagnostic Stability in Patients With Schizoaffective Disorder Compared to Schizophrenia and Bipolar Disorder Bonnie Szarek, R.N.
39. Depression and Its Treatment in Patients Presenting With Late-Onset Delusional Disorder (LODD) Rebecca Anglin, M.D.
Session 14. Psychiatric Issues Related to Pregnancy and Breast Feeding
40. Postpartum Depression and Breast Feeding in an Urban Population of Women in Malaysia Nor Zainal, M.B.B.S., M.Psy.
41. Psychotic Denial of Pregnancy: Ethical and Legal Considerations for Treating Physicians Melissa Nau, M.D.
42. Posttraumatic Growth and Quality of Life in Breast Cancer Patients Derya Iren Akbiyik, M.D., Ph.D.
Session 15. Exploring Suicidality: Assessment and the Impact of Spirituality and Economic Conditions
43. Meeting the Challenge of Risk Assessment: Toward a New Scale of Suicide Assessment: The Scale for Impact of Suicidality Management and Assessment Amresh K. Shrivastava, M.D., D.P.M.
44. Economic Factors and Suicide Rates—Associations Over Time in Four Countries Alfonso Ceccherini-Nelli, M.D.
45. Religion, Spirituality, and Suicide in a Large Community Sample Daniel Rasic, B.S., M.D.
Session 16. Panic and Anxiety Disorder
46. Frequency and Clinical Correlates of Adult Separation Anxiety Disorder in 508 Outpatients With Mood and Anxiety Disorders Stefano Pini, M.D.
47. Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine: A Randomized, Naturalistic, Open Study Antonio Nardi, M.D., Ph.D.
48. Effectiveness of a Mindfulness-Based Cognitive Therapy Program as an Adjunct to Pharmacotherapy in Patients With Panic Disorder Borah Kim, M.D.
Noon-2 p.m.
New ResearchPosters
Poster Session 4
1 p.m.-5 p.m.
CME Courses 67-70
2 p.m.-3:30 p.m.
Lectures
L18. The Movement for Global Mental Health: Why You Should JoinVirkram Patel, M.Sc., M.R.C.Psych., Ph.D., International Lecture
L19. Translational Neuroscience for SchizophreniaAkira Sawa, M.D., Ph.D., Frontiers of Scienc Lecture
2 p.m.-5 p.m.
Advances In Series
A04. Psychosomatic MedicineJames L. Levenson, M.D.
A05. Psychotherapuedic PsychiatryGlen Gabbard, M.D.
A06. Personality DisorderJohn Oldham, M.D.
A07. Forensic PsychiatryRobert I. Simon, M.D., Lisa Gold, M.D.
DSM Track
DSM04. Public Health—Revisions ReviewChair: Norman Sartorius, M.D.
Presidential Symposia PS3. Psychiatry and the Control ofFertilityChair: Gail Robinson, M.D., Co-Chair: Susan Kornstein, M.D.
Symposia
S19. Suicide Without a Psychiatric Disorder
Had Gary Powers Killed Himself Norman B. Levy, M.D. | |||||
Differentiating Suicide From Other Life-Ending Acts: A Model Illustrated With Chronic Kidney Disease and Dialysis John M. Bostwick, M.D. | |||||
Oregon's Death With Dignity Act: Who Chooses Physician-Assisted Suicide Linda Ganzini, M.D. | |||||
Desire for Death in Terminally Ill Cancer and AIDS Patients: Hopelessness and Loss of Meaning as Contributing Factors, Independent of Depression William Breitbart, M.D. | |||||
Ethics in Suicide That Is Not Associated With Psychiatric Illness James J. Strain, M.D. | |||||
S20. Biological Basis of Sex Differences in Drug Addiction: Translational PerspectivesNational Institute on Drug Abuse
Sex Differences in Biological Sensitivity to the Reinforcing Effects of Drugs of Abuse in Preclinical Models of Acquisition, Escalation, and Relapse Wendy J. Lynch, Ph.D. | |||||
The Role of Dopamine in Sex Differences in Drug Abuse Jill B. Becker, Ph.D. | |||||
Gonadal Steroid Hormones and Neural Mechanisms of Cognition and Emotion in Women Karen Faith Berman, M.D. | |||||
Sex Differences in fMRI Correlates of Stress and Drug Cues in Cocaine Dependence Marc N. Potenza, M.D. | |||||
Sex Differences in Amygdala-Based Emotional Memory Processes: Relevance for Addiction Larry F. Cahill, Ph.D. | |||||
S21. Co-occurring Disorders in HIV Positive Patients
HIV and Hepatitis C Co-Infection Elizabeth Ryan, M.D. | |||||
Metabolic Disease and HIV Marshall Forstein, M.D. | |||||
PTSD and HIV Antoine Douaihy, M.D. | |||||
Update on Severe Mental Illness and HIV Francine Cournos, M.D. | |||||
Substance Use Disorders and HIV Steven Batki, M.D. | |||||
S22. Starting Out on the Right Foot: Securing Your First Job and Establishing a Psychiatric PracticeAPA Committee of Residents and Fellows
S23. Social Stress Increases Vulnerability to Drug Abuse and DiseaseNational Institute on Drug Abuse
Adverse Effects of Stress on Drug Addiction Julie Blendy, Ph.D. | |||||
Social Stress and Vulnerability to Substance Abuse: Genes, Environment, and Neural Correlates Huda Akil, Ph.D. | |||||
Interactions of Social Stressors and Enrichment With Social Rank on Dopamine D2 Receptors and the Reinforcing Strength of Cocaine in Monkeys Michael A. Nader, Ph.D. | |||||
Social Stress and Simian Immunodeficiency Virus Disease: Behavioral and Physiological Mechanisms That Affect Disease Progression John P. Capitanio, Ph.D. | |||||
S24. What's New in Pharmacotherapy for Alcohol Dependence?National Institute on Alcohol Abuse and Alcoholism
Neurokinin 1 Receptor (NK1R) Antagonism: A Novel Anti-Stress Mechanism for the Treatment of Alcoholism David Ted George, M.D. | |||||
Human Laboratory and Clinical Trial Evidence for Gabapentin Treatment of Alcohol Dependence Barbara J. Mason, Ph.D. | |||||
Update on New Clinical Trials for Alcohol Dependence: Opiate, Dopamine, and GABA/Glutamate Acting Medications Raymond F. Anton, M.D. | |||||
An Analysis of Two Promising Medications, Topiramate and Ondansetron, for Treating Alcohol Dependence: Results From Recent Large-Scale Clinical Trials Bankole A. Johnson, D.Sc. | |||||
Pharmacogenetics and Alcohol Dependence Henry R. Kranzler, M.A. | |||||
S25. Autism in Adults—Toward a Better Clinical Approach Through Understanding: Recent Insights From Research
Neurodevelopmental Correlates of Social Impairment in Autism: From Infancy to Adulthood Ami Klin, Ph.D. | |||||
Diffusion Tensor Imaging in Autism and Asperger Syndrome: Evidence for Impairment of Long Range White Matter Integrity Wouter Groen, M.D. | |||||
Neurocognitive Correlates of Substance Use Disorder in Adults With Autism Spectrum Disorder or ADHD Bram B. Sizoo, M.D. | |||||
Comorbidity in Adults With ASD: Evidence From Data From Cross-Sectional and Prospective Case-Controlled Cohort Samples Patricia J. van Wijngaarden-Cremers, M.D. | |||||
ASD in Parents and Siblings of Early Diagnosed Infants With ASD Rutger J. Van der Gaag, M.D. | |||||
S26. The Effects of City Life on Mental Health Around the WorldRoyal College of Psychiatrists
The Impact of Urban Living on Mental Health and Illness in Egypt Nasser N. Loza, M.D. | |||||
Mental Disorders and Quality of Life in Large Metropolitan Areas in Mexico Maria E. Medina Mora, Psy.D. | |||||
Metro-Urban Mental Health in Developing Countries: From Origins to Outcome: An Indian Experience Amresh K.A. Shrivastava, M.D. | |||||
A Population-Based Study of First Episode Psychosis in São Paulo, Brazil Paulo Menezes, M.D. | |||||
Chinese Elderly in Singapore: Comparing the Mental Health of an Urban and a Suburban Population Ee-Heok Ehk Kua, M.B.B.S. | |||||
The Practice of Mental Health Promotion in Urban Planning and City Administration Helen E. Herrman, M.B. | |||||
S27. Recent Research in Eating Disorders
Psychopathology and Eating Pathology in Bariatric Surgery Candidates James E. Mitchell, M.D. | |||||
Disordered Eating and Psychiatric Symptoms in Adolescents Presenting for Bariatric Surgery Michael J. Devlin, M.D. | |||||
Recent Mortality Studies in Eating Disorders Scott J. Crow, M.D. | |||||
A Model of Allostasis for Conceptualizing Eating Disorders Katherine A. Halmi, M.D. | |||||
Are Anorexia Nervosa and Bulimia Nervosa Really Eating Disorders: New Understanding of Puzzling Symptoms Walter H. Kaye, M.D. | |||||
S28. Publication Bias and the Effectiveness of Antidepressant Treatment and Psychological Interventions in Depression: Should We Care?
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy Erick H. Turner, M.D. | |||||
Publication Bias Is Not Restricted to Reporting Outcomes of Pharmacotherapy Trials Willem W.A. Nolen, M.D. | |||||
Nonresponse to CBT and Antidepressants in the Treatment of Depression in Myocardial Infarction Patients Elisabeth Martens, M.D. | |||||
How Well Do We Treat MDD? Claudi C.L.H. Bockting, Ph.D. | |||||
S29. Borderline Personality Disorder:The Role of Neurobiology and Genes
Opioid Receptor and Oxytocin Genotypes in BPD Larry J. Siever, M.D. | |||||
Dysregulation of Endogenous Opioid System Function in Borderline Personality Disorder Jon-Kar Zubieta, M.D. | |||||
Pain Processing in Borderline Personality Disorder: Functional and Genetic Approach Martin Bohus | |||||
Neurobiology of Self-Injury in Borderline Personality Disorder Barbara H. Stanley, Ph.D. | |||||
S30. Current and Future of the Emergent Field of Therapeutic Brain Stimulation and Neuromodulation in Psychiatry
Neurosurgery for OCD: Focus on Deep Brain Stimulation Benjamin D. Greenberg, M.D. | |||||
Feasibility Study of an Implantable Cortical Stimulation System for Patients With Major Depressive Disorder Darin D. Dougherty, M.D. | |||||
Deep Transcranial Magnetic Stimulation: Comparison Between Effects of Unilateral and Bilateral Prefrontal Cortex Stimulation in Depressive Patients Abraham Zangen, Ph.D. | |||||
Current and Future Therapeutic Uses of rTMS Mark S. George, M.D. E. Current and Future of Other Brain-Stimulating Techniques Alexander Bystritsky, M.D. | |||||
S31. Pediatric Bipolar Disorder: A Critical Look at an American Phenomenon
Australian and New Zealand Child and Adolescent Psychiatrists' Views on Bipolar Disorder Prevalence and on Rates of Pediatric Bipolar Disorder in the USA Peter I. Parry, M.B.B.S. | |||||
Changing the Treatment Culture in a Residential Agency for Youth: Broadening the Role of Psychiatry Edmund C. Levin, M.D. | |||||
Pediatric Bipolar Disorder: A Dispassionate Review of the Literature Glen R. Elliott, M.D. | |||||
Bioethics and “Pediatric Bipolar Disorder” Mary G. Burke, M.D. | |||||
S32. Working With Lawyers
Values of Medicine and the Law Roger Peele, M.D. | |||||
Brownlee v. Me: A Good Lawyer Directs the Process and Gets a Favorable Summary Judgment Lawrence K. Richards, M.D. | |||||
New Opportunities for Attorney/Psychiatrist Collaborations Bruce J. Winick | |||||
Beyond “Get the Money Up Front” Thomas G. Gutheil, M.D. | |||||
Working With Lawyers Harold I. Eist, M.D. | |||||
S33. Empirically Validated and Effective Psychotherapies for Borderline Personality Disorder
Evidence-Based Versus Effectiveness Studies: The Randomized, Controlled Trial and Psychotherapy Research Kenneth R. Silk, M.D. | |||||
Mentalization Based Treatment: A Discussion of Theory and Evidence Anthony W. Bateman, M.R.C. | |||||
Transference-Focused Psychotherapy for BPD: Aiming for Change in Personality Structure Frank E. Yeomans, M.D. | |||||
Dialectical Behavior Therapy for Complex, Multi-Diagnostic Patients—A Review of DBT's Evidence Base to Date Linda A. Dimeff, Ph.D. | |||||
CBT for Personality Disorders (CBT-PD) Kate M. Davidson, Ph.D. | |||||
Schema Therapy for Borderline Personality Disorder Jeffrey E. Young, Ph.D. | |||||
S34. Advances in Neuropsychiatry and Clinical Neurosciences
Windows to the Brain: Clinical and Functional Imaging in Psychiatry Robin A. Hurley, M.D. | |||||
Current Controversies and Research Oportunities in the Neuropsychiatric Aspects of Delirium Paula Trzepacz, M.D. | |||||
Neuropsychiatry of Traumatic Brain Injury Jonathan Silver, M.D. | |||||
Advances in Neuropsychiatric Disorders Associated With Cerebrovascular Disease Robert G. Robinson, M.D. | |||||
S35. PTSD and Alcohol Use Disorder (With Special Emphasis on Returning Veterans)National Institute on Alcohol Abuse and Alcoholism
Psychotherapy Treatments for PTSD and Alcohol Use Disorder Lisa M. Najavits, Ph.D. | |||||
Neurobiological Determinants of the Comorbidity of PTSD and Substance Abuse Thomas R. Kosten, M.D. | |||||
Pharmacotherapeutic Treatment of PTSD and Co-Occurring Alcohol Use Disorders Kathleen Brady, M.D. | |||||
Outcomes for Alcohol-Misusing Women With PTSD in the Women and Trauma Multisite Study in NIDA's Clinical Trials Network Denise Hien, Ph.D. | |||||
Impact of Childhood Trauma on Hypothalamic-Pituitary-Adrenocorticol (HPA) Activity in Alcohol-Dependent Patients Ingo Schäfer, M.D. | |||||
S36. Psychiatric Patients' Overcrowding in Emergency Departments: A Call for ActionsAPA Council on Healthcare Systems and Financing
Overview of Psychiatric Patient Overcrowding in Emergency Departments Scott L. Zeller, M.D. | |||||
Health Care Delivery System Influences and Impacts—Strategies for Improvement Joseph J. Parks, M.D. | |||||
Innovative Methods to Decrease Psychiatric Patient Overcrowding of Medical Emergency Departments Avrim B. Fishkind, M.D. | |||||
Behavioral Health Service Gaps and the Role of Emergency Departments Alan Q. Radke, M.D. | |||||
3 p.m.-5 p.m.
New Research Poster Session 5
5 p.m.-6 p.m.
MindGames
7 p.m.-10 p.m.
Industry-Supported Symposia ▪
